Epitope-tagging approach to determine the stoichiometry of the structural and nonstructural proteins in the virus particles: Amount of Vpr in relation to Gag in HIV-1

Virology

Volumn 268, Issue 2, 2000, Pages 364-371

  Singh, Satya P ^a   Lai, Derhsing ^a   Cartas, Maria ^a   Serio, Dawn ^a   Murali, Ramachandran ^b   Kalyanaraman, Vaniambadi S ^c   Srinivasan, Alagarsamy ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c ADVANCED BIOSCIENCE LABORATORIES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAG PROTEIN;

ARTICLE; GENE CONSTRUCT; GENE DISRUPTION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RNA TRANSLATION; STOICHIOMETRY; VIRUS PARTICLE;

ANIMALIA; DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0034653938     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0191     Document Type: Article

References (53)

1. Arthur L. O., Bess J. W. Jr., Sowder R. C. II, Benveniste R. E., Mann D. L., Chermann J. C., Henderson L. E. Cellular proteins bound to immunodeficiency viruses: Implications for pathogenesis and vaccines. Science. 258:1992;1935-1938.
2. Bouhamdan M., Benichou S., Rey F., Navarro J. M., Agostini I., Spire B., Camonis J., Slupphaug G., Vigne R., Benarous R., Sire J. Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme. J. Virol. 70:1996;697-704.
3. Camaur D., Trono D. Characterization of human immunodeficiency virus type 1 Vif particle incorporation. J. Virol. 70:1996;6106-6111.
4. Checroune F., Xao X. J., Gottlinger H. G., Bergeron D., Cohen E. A. Incorporation of Vpr into human immunodeficiency virus type 1: Role of conserved regions within the P6 domain of Pr55gag. J. Acquir. Immune Defic. Syndr. 10:1995;1-7.
5. Chubet R. G., Brizzard B. L. Vectors for expression and secretion of FLAG epitope-tagged proteins in mammalian cells. Biotechniques. 20:1996;136-141.
6. Cohen E. A., Dehni G., Sodroski J. G., Haseltine W. A. Human immunodeficiency virus vpr product is a virion associated regulatory protein. J. Virol. 64:1990;3097-3099.
7. Cohen E. A., Subbramanian R. A., Gottlinger H. G. Role of auxiliary proteins in retroviral morphogenesis. Curr. Topics Microbiol. Immunol. 214:1996;219-235.
8. Cullen B. R. HIV-1 auxiliary proteins: Making connections in a dying cell. Cell. 93:1998;685-692.
9. de Rocquigny H., Petitjean P., Tanchou V., Decimo D., Drouot L., Darlix J. L., Roques B. P. The zinc fingers of HIV nucleocapsid protein NCp7 direct interactions with the viral regulatory protein Vpr. J. Biol. Chem. 272:1997;30753-30759.
10. Dettenhofer M., Yu X-F. Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions. J. Virol. 73:1999;1460-1467.
11. Di Marzio P., Choe S., Elbright M., Knoblauch R., Landau N. Mutational analysis of cell cycle arrest, nuclear localization, and virion packaging of human immunodeficiency virus type 1 Vpr. J. Virol. 69:1995;7909-7916.
12. Emerman M. HIV-1 Vpr and the cell cycle. Curr. Biol. 6:1996;1096-1103.
13. Fields, B. N., Knipe, D. M., and Howley, P. M.1996. Fields' Virology, Vol. 2, 3rd ed., Lippincott-Raven, Philadelphia.
14. Fletcher T. M. III, Soares M. A., McPhearson S., Hui H., Wiskerchen M., Muesing M. A., Shaw G. M., Leavitt A. D., Boeke J. D., Hahn B. H. Complementation of integrase function in HIV-1 virions. EMBO J. 16:1997;5123-5138.
15. Fouchier R. A. M., Meyer B. E., Simon J. H. M., Fischer U., Albright A. V., Gonzalez-Scarano F., Malim M. M. Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex. J. Virol. 72:1998;6004-6013.
16. Gragerov A., Kino T., Ilyina-Gragerara G., Chrousos G. P., Pavlakis G. N. HHR23A, the human homologue of the yeast repair protein RAD23, interacts specifically with Vpr protein and prevent cell cycle arrest but not the transcriptional effects of Vpr. Virology. 245:1998;323-330.
17. cdc2 activity. J. Virol. 69:1995;6705-6711.
18. Heinzinger N. K., Bukrinsky M. I., Haggerty S. A., Ragland A. M., Kewalramani V., Lee M. A., Gendelman H. E., Ratner L., Stevenson M., Emerman M. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in non dividing host cells. Proc. Natl. Acad. Sci. USA. 91:1994;7311-7315.
19. Henderson L. E., Sowder T. D., Copeland R. E., Beneveniste R. E., Oroszlan S. Isolation and characterization of a novel protein (X-ORF product) from SIV and HIV-2. Science. 241:1988;199-201.
20. Hunter E. Macromolecular interactions in the assembly of HIV and other retroviruses. Semin. Virol. 5:1994;71-83.
21. Jowett J. B. M., Planelles V., Poon B., Shah N. P., Chen M.-L., Chen I. S. Y. The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J. Virol. 69:1995;6304-6313.
22. Kobinger G. P., Borsetti A., Nie Z., Mercier J., Daniel N., Gottlinger H. G., Cohen E. A. Virion-targeted viral inactivation of human immunodeficiency virus type 1 by using Vpr fusion proteins. J. Virol. 72:1998;5441-5448.
23. Kondo E., Mammano F., Cohen E. A., Gottlinger H. G. The p6 gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous virus particles. J. Virol. 69:1995;2759-2764.
24. Lavallee C., Yao X. J., Ladha H., Gottlinger H. G., Haseltine W., Cohen E. A. Requirement of the Pr55 gag precursor for incorporation of the vpr product into human immunodeficiency virus type 1 viral particle. J. Virol. 68:1994;1926-1934.
25. Levy, J. A. 1998, HIV and the Pathogenesis of AIDS, ASM Press, Washington, DC.
26. Liu H., Wu X., Newman M., Shaw G. M., Hahn B. H., Kappes J. C. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associated with viral core structures. J. Virol. 69:1995;7630-7638.
27. gag is important for Vpr incorporation in human immunodeficiency virus type 1 particles. J. Virol. 69:1995;6873-6879.
28. Lu Y.-L., Spearman P., Ratner L. Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J. Virol. 67:1993;6542-6550.
29. Luciw, P. A.1996. Human immunodeficiency viruses and their replication. InFields' Virology (B. N. Fields, D. M., Knipe, and P. M. Howley, Eds.), pp. 1881-1952. Lippincolt-Raven, Philadelphia.
30. Luo Z., Butcher D. J., Murali R., Srinivasan A., Huang Z. Structural studies of synthetic peptide fragments derived from the HIV-1 Vpr protein. Biochem. Biophys. Res. Commun. 244:1998;732-736.
31. Mahalingam S., Khan S. A., Murali R., Jabbar M. A., Monken C. E., Collman R. G., Srinivasan A. Mutagenesis of the putative α-helical domain of the Vpr protein of human immunodeficiency virus type 1: Effect on stability and virion incorporation. Proc. Natl. Acad. Sci. USA. 92:1995;3794-3798.
32. Nagashunmugam T., Velpandi A., Goldsmith C. S., Zaki S. R., Kalyanaraman V. S., Srinivasan A. Mutation in the primer binding site of the type 1 human immunodeficiency virus genome affects virus production and infectivity. Proc. Natl. Acad. Sci. USA. 89:1992;4114-4118.
33. Nie Z., Bergeron D., Subbramanian R. A., Yao X. J., Checroune F., Rougeau N., Cohen E. A. The putative alpha helix 2 of human immunodeficiency virus type 1 Vpr contains a determinant which is responsible for the nuclear translocation of proviral DNA in growth-arrested cells. J. Virol. 72:1998;4104-4115.
34. Okui N., Kobayashi N., Kitamura Y. Production of uninfectious human immunodeficiency virus type 1 containing viral protein R fused to a single-chain antibody against viral integrase. J. Virol. 72:1998;6960-6964.
35. Paxton W., Connor R. I., Landau N. The p6 gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous virus particles. J. Virol. 67:1993;7229-7237.
36. Piller S. C., Ewart G. D., Premkumar A., Cox G. B., Gage P. W. Vpr protein of human immunodeficiency virus type 1 forms cation-selective channels in planar lipid bilayers. Proc. Natl. Acad. Sci. USA. 93:1996;111-115.
37. Refaeli Y., Levy D. N., Weiner D. B. The glucocorticoid receptor type II complex is a target of the HIV-1 Vpr gene product. Proc. Natl. Acad. Sci. USA. 92:1995;3621-3625.
38. cdc2-cyclin B. J. Virol. 69:1995;6859-6864.
39. Rogel M. E., Wu L. I., Emerman M. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J. Virol. 69:1995;882-888.
40. Sato A., Yoshimoto J., Isaka Y., Miki S., Suyama A., Hayami M., Fujiwara T., Yoshie O. Evidence for direct association of Vpr and Matrix protein p17 within the HIV-1 virion. Virology. 220:1996;208-212.
41. Serio D., Rizvi T. A., Cartas M., Kalyanaraman V. S., Weber I. T., Koprowski H., Srinivasan A. Development of a novel anti-HIV-1 agent from within: Effect of chimeric Vpr containing protease cleavage site residues on virus replication. Proc. Natl. Acad. Sci. USA. 94:1997;3346-3351.
42. Serio D., Weber I. T., Harrison R. W., Louis J. M., Srinivasan A. Epitope-based assay to determine the efficiency of cleavage by HIV-1 protease. Biotechniques. 26:1999;242-246.
43. Simon J. H. M., Miller D. L., Fouchier R. A. M., Malim M. Virion incorporation of human immunodeficiency virus type-1 Vif is determined by intracellular expression level and may not be necessary for function. Virology. 248:1998;182-187.
44. Stark L. A., Hay R. T. Human immunodeficiency virus type 1 (HIV-1) viral protein R (Vpr) interact with Lys-tRNA synthetase: Implications for priming of HIV-1 reverse transcription. J. Virol. 72:1998;3037-3044.
45. Subbramanian R. A., Yao X. J., Dilhuydy H., Rougeau N., Bergeron D., Robitaille Y., Cohen E. A. Human immunodeficiency virus type 1 Vpr localization: Nuclear transport of a viral protein modulated by a putative amphipathic helical structure and its relevance to biological activity. J. Mol. Biol. 278:1998;13-30.
46. Tristem M., Marshall C., Karpas A., Hill F. Evolution of the primate lentiviruses: evidence from vpx and vpr. EMBO J. 11:1992;3405-3412.
47. Tung H. Y. L., Rocquigny De., Zhao H., Cayla L.-J. X., Roques B. P., Ozon R. Direct activation of protein phosphatase-2Ao by HIV-1 encoded protein complex Ncp7: Vpr. FEBS Lett. 401:1997;197-201.
48. Welker R., Kotler H., Kalbitzer H. R., Krausslich H. G. Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase. Virology. 219:1996;228-236.
49. Wu X., Liu H., Xiao H., Conway J. A., Kappes J. C. Inhibition of human and simian immunodeficiency virus protease function targeting Vpx-protease-mutant fusion protein into viral particles. J. Virol. 70:1996;3378-3384.
50. Wu X., Liu H., Xiao H., Conway J. A., Hunter E., Kappes J. C. Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein. EMBO J. 16:1997;5113-5122.
51. Yao X. J., Subbramanian R. A., Rougeau N., Boisvert F., Bergeron D., Cohen E. A. Mutagenic analysis of human immunodeficiency virus type 1 Vpr: Role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation. J. Virol. 69:1995;7032-7044.
52. Zhao L. J., Mukherjee S., Narayan O. Biochemical mechanism of HIV-1 Vpr function: Specific interaction with a cellular protein. J. Biol. Chem. 269:1994a;15577-15582.
53. Zhao L. J., Wang L., Mukherjee S., Narayan O. Biochemical mechanism of HIV-1 Vpr function: Oligomerization mediated by the N-terminal domain. J. Biol. Chem. 269:1994b;32131-32137.